Revolution Medicines, Inc.
BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Status:
Application
Type:

Utility

Filling date:

2 Mar 2020

Issue date:

5 May 2022